Physician profile
Scott Musicant
NPI 1174617070
$59,313.38
in general payments reported to CMS, 2019-2025
59 companies · $2,366 in 2025
The $2,366 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,627 · 2021: $4,185 · 2022: $19K · 2023: $6,108 · 2024: $9,674 · 2025: $2,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $5,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,137.50 |
| Food and Beverage | $5,010.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $23,366.60 | 2022-2024 | Solus Alif |
| Silk Road Medical, INC. | $20,227.86 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cvrx, INC. | $3,595.04 | 2021-2025 | Barostim Neo System |
| Nuvasive, INC. | $2,012.54 | 2019 | |
| Medtronic, INC. | $1,555.24 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Medtronic Vascular, INC. | $1,534.50 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $790.59 | 2019-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter, Crosser Iq |
| W. L. Gore & Associates, INC. | $718.18 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Boston Scientific Corporation | $462.62 | 2019-2025 | Enroute Transcarotid Stent, Ranger, Varithena Administration Pack |
| Cook Medical LLC | $456.09 | 2019-2025 | Zenith Spiral-Z |
| Endologix LLC | $358.35 | 2023-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Merz North America, INC. | $341.03 | 2021-2022 | |
| Inari Medical, INC. | $246.90 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $231.58 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $230.07 | 2019-2023 | Xarelto |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $224.00 | 2024-2025 | Arista, Venclose Maven Catheter |
| Cardiovascular Systems INC. | $215.15 | 2019-2023 | Diamondback Peripheral |
| Allergan, INC. | $176.32 | 2021-2022 | |
| Bolton Medical INC | $174.18 | 2023-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System, Thoraflex Hybrid |
| Abbott Laboratories | $148.98 | 2023-2025 | Diamondback Peripheral, Jeti All In One Non-Sterile Kit, Esprit |
| Angiodynamics, INC. | $147.61 | 2020-2023 | Alphavac |
| Biocompatibles, INC. | $142.93 | 2019 | |
| Tactile Systems Technology INC | $141.42 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Ekos Corporation | $138.89 | 2019 | |
| Microtransponder, INC. | $126.03 | 2025 | |
| Venclose INC. | $117.12 | 2020 | |
| Inspiremd LTD | $116.71 | 2025 | Cguard Prime Carotid Stent System |
| Stryker Corporation | $109.99 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Getinge USA Sales, LLC | $103.77 | 2021 | |
| Penumbra, INC. | $101.80 | 2019-2022 | |
| Terumo Medical Corporation | $87.53 | 2021-2023 | Angio-Seal |
| Musculoskeletal Transplant Foundation INC. | $82.69 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $64.66 | 2023-2024 | Andexxa |
| Chiesi USA, INC. | $58.90 | 2022-2024 | Kengreal, Cleviprex |
| Kerecis Limited | $58.00 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Philips North America LLC | $56.79 | 2021 | |
| Convatec INC. | $49.81 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $48.83 | 2021-2022 | |
| Smith+Nephew, INC. | $40.76 | 2025 | Collagenase Santyl |
| Imperative Care, INC | $37.19 | 2024-2025 | Prodigy Catheter, Symphony Catheter |
| Aroa Biosurgery Incorporated | $33.60 | 2023 | |
| Ethicon US, LLC | $30.88 | 2024 | Dermabond Prineo, Vistaseal |
| Merck Sharp & Dohme LLC | $30.61 | 2023 | Bridion |
| Amgen INC. | $29.87 | 2021-2023 | Repatha |
| Reflow Medical INC | $23.41 | 2024 | |
| Biotissue Holdings INC. | $22.55 | 2022 | |
| Cardiva Medical, INC. | $22.51 | 2023 | Cardiva Vascade 6/7f Vcs |
| Lemaitre Vascular, INC. | $22.42 | 2019 | |
| Acera Surgical, INC. | $22.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.79 | 2024 | Exparel |
| Teleflex LLC | $20.99 | 2021 | |
| Surmodics, INC. | $20.76 | 2022 | |
| Pfizer INC. | $18.65 | 2021 | |
| Cordis US Corp. | $18.30 | 2022 | |
| Humacyte Global, INC. | $17.31 | 2025 | Symvess |
| Becton, Dickinson and Company | $17.16 | 2023 | Lutonix Drug Coated Balloon |
| Cagent Vascular INC | $15.77 | 2024 | Serrantor |
| Cardinal Health 200 LLC | $14.29 | 2021 | |
| Depuy Synthes Sales INC. | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Musicant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.